High Pressure Processing Impact on Emerging Mycotoxins (ENNA, ENNA1, ENNB, ENNB1) Mitigation in Different Juice and Juice-Milk Matrices

The aim of the present study was to investigate the potential of high-pressure processing (HPP) (600 MPa during 5 min) on emerging mycotoxins, enniatin A (ENNA), enniatin A1 (ENNA1), enniatin B (ENNB), enniatin B1 (ENNB1) reduction in different juice/milk models, and to compare it with the effect of a traditional thermal treatment (HT) (90 °C during 21 s). For this purpose, different juice models (orange juice, orange juice/milk beverage, strawberry juice, strawberry juice/milk beverage, grape juice and grape juice/milk beverage) were prepared and spiked individually with ENNA, ENNA1, ENNB and ENNB1 at a concentration of 100 µg/L. After HPP and HT treatments, ENNs were extracted from treated samples and controls employing dispersive liquid-liquid microextraction methodology (DLLME) and determined by liquid chromatography coupled to ion-trap tandem mass spectrometry (HPLC-MS/MS-IT). The results obtained revealed higher reduction percentages (11% to 75.4%) when the samples were treated under HPP technology. Thermal treatment allowed reduction percentages varying from 2.6% to 24.3%, at best, being ENNA1 the only enniatin that was reduced in all juice models. In general, no significant differences (p > 0.05) were observed when the reductions obtained for each enniatin were evaluated according to the kind of juice model, so no matrix effects were observed for most cases. HPP technology can constitute an effective tool in mycotoxins removal from juices.

Determination of favipiravir in human plasma using homogeneous liquid–liquid microextraction followed by HPLC/UV

Background: Favipiravir is an antiviral drug that was recently approved for the management of COVID-19 infection. Aim: This work aimed to develop a new method, using sugaring-out induced homogeneous liquid–liquid microextraction followed by HPLC/UV for the determination of favipiravir in human plasma. Materials & methods: The optimum extraction conditions were attained using 500 μl of tetrahydrofuran as an extractant and 1400 mg of fructose as a phase-separating agent. Results: The developed method was validated according to the US FDA bioanalytical guidelines and was found linear in the range of 25-80,000 ng/ml with a correlation coefficient of 0.999. Conclusion: These results showed that the developed method was simple, easy, valid and adequately sensitive for determination of favipiravir in plasma for bioequivalence studies.

Fast Dispersive Liquid-Liquid Microextraction Based on Temperature Switching Deep Eutectic Solvent as A Green Extractant

With the development of research, it was found that the dispersive liquid-liquid microextraction (DLLME) was limited by the tedious extraction process and toxic extractant. A thermo-switchable deep eutectic solvent (DES) was applied to the DLLME as a green extractant in this paper. The DES can be dispersed and aggregated by shaking and heating in the water during the extraction process due to the surfactant and thermo-switchable properties, which shortened the extraction time as low as 5 minutes. The feasibility of the developed method was verified using 4 organophosphorus pesticides and 5 pyrethroids as targets in simulated water samples, which showed good precision (RSD%, 0.8-9.7, n=3) and low detection limit (0.16-0.81 µg L−1, S/N = 3) under the optimal extraction conditions. This method was used to detect the pesticide content in four natural rivers in Xi'an, and the recoveries of these spiked samples at three concentrations levels were among 81–113%. This is the first time to combine the toxic-free and thermo-switchable properties of DES in DLLME to proposes a simple, fast, effective, and green pretreatment method.